Poly(ADP-Ribose) polymerase inhibition: "targeted" therapy for triple-negative breast cancer.

Anders, Carey K; Winer, Eric P; Ford, James M; Dent, Rebecca; Silver, Daniel P; Sledge, George W; Carey, Lisa A

Anders, Carey K; Winer, Eric P; Ford, James M; Dent, Rebecca; Silver, Daniel P; Sledge, George W; Carey, Lisa A.

Affiliation

Anders CK; University of North Carolina, Chapel Hill, 27517, USA. carey_anders@med.unc.edu

Clin Cancer Res ; 16(19): 4702-10, 2010 Oct 01.

Article in En | MEDLINE | ID: mdl-20858840

Subject(s)

Antineoplastic Agents/pharmacology; Antineoplastic Agents/therapeutic use; Breast Neoplasms/drug therapy; Breast Neoplasms/enzymology; Enzyme Inhibitors/pharmacology; Enzyme Inhibitors/therapeutic use; Poly(ADP-ribose) Polymerase Inhibitors; Disease Progression; Female; Humans

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Enzyme Inhibitors / Poly(ADP-ribose) Polymerase Inhibitors / Antineoplastic Agents Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Clin Cancer Res Year: 2010 Document type: Article

Fulltext

XML

PubMed Links

Search on Google